Sanofi’s PERSEUS phase 3 study of tolebrutinib in primary progressive multiple sclerosis fails to meet primary endpoint: Paris Tuesday, December 16, 2025, 11:00 Hrs [IST] Sanofi ...
Check exam timings, marking schemes, paper patterns, sample papers, and scoring topics here., Education, Times Now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback